To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: DG DISPATCH - HEADACHE: Sumatriptan Non-Responders Often Have Other Personality Disorders URL: http://www.pslgroup.com/dg/10C932.htm Doctor's Guide June 25, 1999
By Cameron Johnston Special to DG News
BARCELONA, SPAIN -- June 25, 1999 -- Patients who don't respond to the drug Imitrex (sumatriptan, Glaxo-Wellcome) for their migraine headaches seem to show distinct physiological, psychiatric and psychological differences from those who do respond to the drug, a researcher reported at the 9th International Headache Society meeting, in Barcelona, Spain.
The study, conducted by Dr. Werner Becker and colleagues at the University of Calgary Headaches Clinic, involved 49 people who did respond to sumatriptan and 25 who did not. Women outnumbered men by approximately six to one. The participants completed a headache questionnaire as well as a personality inventory and a diagnostic interview.
While women who experienced menstrual migraines were more likely to be controls - that is to say they responded to sumatriptan - those who did not respond were more likely to suffer from generalized anxiety disorder.
There was no history of drug, alcohol or other substance abuse between the groups, but when the subjects were evaluated for 16 points on the personality inventory, significant differences emerged. Non-responders, for example, were deemed to be more impatient, self-disciplined and loners than controls.
Dr. Werner Becker speculated that this diffirence could indicate that biological differences account for the personality variations and the fact that one group responds to treatment for their migraines, while the other does not.
The biological difference, he maintains, may be manifested in non-responders in several ways including the fact that they are less prone to menstrual migraines but more likely to suffer from anxiety disorder. Their personality characteristics may lead them to be described as "unconventional, detached, solitary and compulsive, and driven", Dr. Becker said.
Related Links: Imitrex, Glaxo-Wellcome --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.